HEADER    IMMUNE SYSTEM                           06-JUN-02   1LY2              
TITLE     CRYSTAL STRUCTURE OF UNLIGANDED HUMAN CD21 SCR1-SCR2 (COMPLEMENT      
TITLE    2 RECEPTOR TYPE 2)                                                     
COMPND    MOL_ID: 1;                                                            
COMPND   2 MOLECULE: COMPLEMENT RECEPTOR TYPE 2;                                
COMPND   3 CHAIN: A;                                                            
COMPND   4 SYNONYM: CD21; EPSTEIN-BARR VIRUS RECEPTOR;                          
COMPND   5 ENGINEERED: YES                                                      
SOURCE    MOL_ID: 1;                                                            
SOURCE   2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;                                   
SOURCE   3 ORGANISM_COMMON: HUMAN;                                              
SOURCE   4 ORGANISM_TAXID: 9606;                                                
SOURCE   5 GENE: CR2;                                                           
SOURCE   6 EXPRESSION_SYSTEM: PICHIA PASTORIS;                                  
SOURCE   7 EXPRESSION_SYSTEM_TAXID: 4922;                                       
SOURCE   8 EXPRESSION_SYSTEM_STRAIN: X-33;                                      
SOURCE   9 EXPRESSION_SYSTEM_VECTOR: PICZA (INVITROGEN) SECRETED PROTEIN        
KEYWDS    COMPLEMENT RECEPTOR; EPSTEIN BARR VIRUS; REGULATOR OF COMPLEMENT      
KEYWDS   2 ACTIVATION; SHORT CONSENSUS REPEAT; VIRAL RECEPTOR; COMPLEMENT       
KEYWDS   3 CONTROL PROTEIN, IMMUNE SYSTEM                                       
EXPDTA    X-RAY DIFFRACTION                                                     
AUTHOR    A.E.PROTA,D.R.SAGE,T.STEHLE,J.D.FINGEROTH                             
REVDAT   5   29-JUL-20 1LY2    1       COMPND REMARK SEQADV HETNAM              
REVDAT   5 2                   1       LINK   SITE                              
REVDAT   4   13-JUL-11 1LY2    1       VERSN                                    
REVDAT   3   24-FEB-09 1LY2    1       VERSN                                    
REVDAT   2   23-AUG-02 1LY2    1       JRNL   AUTHOR                            
REVDAT   1   05-JUL-02 1LY2    0                                                
JRNL        AUTH   A.E.PROTA,D.R.SAGE,T.STEHLE,J.D.FINGEROTH                    
JRNL        TITL   THE CRYSTAL STRUCTURE OF HUMAN CD21: IMPLICATIONS FOR        
JRNL        TITL 2 EPSTEIN-BARR VIRUS AND C3D BINDING.                          
JRNL        REF    PROC.NATL.ACAD.SCI.USA        V.  99 10641 2002              
JRNL        REFN                   ISSN 0027-8424                               
JRNL        PMID   12122212                                                     
JRNL        DOI    10.1073/PNAS.162360499                                       
REMARK   2                                                                      
REMARK   2 RESOLUTION.    1.80 ANGSTROMS.                                       
REMARK   3                                                                      
REMARK   3 REFINEMENT.                                                          
REMARK   3   PROGRAM     : X-PLOR                                               
REMARK   3   AUTHORS     : BRUNGER                                              
REMARK   3                                                                      
REMARK   3  DATA USED IN REFINEMENT.                                            
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80                           
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 20.00                          
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000                          
REMARK   3   DATA CUTOFF HIGH         (ABS(F)) : NULL                           
REMARK   3   DATA CUTOFF LOW          (ABS(F)) : NULL                           
REMARK   3   COMPLETENESS (WORKING+TEST)   (%) : NULL                           
REMARK   3   NUMBER OF REFLECTIONS             : 11265                          
REMARK   3                                                                      
REMARK   3  FIT TO DATA USED IN REFINEMENT.                                     
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT                      
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM                          
REMARK   3   R VALUE            (WORKING SET) : 0.179                           
REMARK   3   FREE R VALUE                     : 0.234                           
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 10.000                          
REMARK   3   FREE R VALUE TEST SET COUNT      : 1127                            
REMARK   3   ESTIMATED ERROR OF FREE R VALUE  : NULL                            
REMARK   3                                                                      
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.                                  
REMARK   3   TOTAL NUMBER OF BINS USED           : NULL                         
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : NULL                         
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : NULL                         
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : NULL                         
REMARK   3   REFLECTIONS IN BIN    (WORKING SET) : NULL                         
REMARK   3   BIN R VALUE           (WORKING SET) : NULL                         
REMARK   3   BIN FREE R VALUE                    : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET SIZE  (%) : NULL                         
REMARK   3   BIN FREE R VALUE TEST SET COUNT     : NULL                         
REMARK   3   ESTIMATED ERROR OF BIN FREE R VALUE : NULL                         
REMARK   3                                                                      
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.                    
REMARK   3   PROTEIN ATOMS            : 996                                     
REMARK   3   NUCLEIC ACID ATOMS       : 0                                       
REMARK   3   HETEROGEN ATOMS          : 28                                      
REMARK   3   SOLVENT ATOMS            : 146                                     
REMARK   3                                                                      
REMARK   3  B VALUES.                                                           
REMARK   3   FROM WILSON PLOT           (A**2) : NULL                           
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : NULL                           
REMARK   3   OVERALL ANISOTROPIC B VALUE.                                       
REMARK   3    B11 (A**2) : NULL                                                 
REMARK   3    B22 (A**2) : NULL                                                 
REMARK   3    B33 (A**2) : NULL                                                 
REMARK   3    B12 (A**2) : NULL                                                 
REMARK   3    B13 (A**2) : NULL                                                 
REMARK   3    B23 (A**2) : NULL                                                 
REMARK   3                                                                      
REMARK   3  ESTIMATED COORDINATE ERROR.                                         
REMARK   3   ESD FROM LUZZATI PLOT        (A) : NULL                            
REMARK   3   ESD FROM SIGMAA              (A) : NULL                            
REMARK   3   LOW RESOLUTION CUTOFF        (A) : NULL                            
REMARK   3                                                                      
REMARK   3  CROSS-VALIDATED ESTIMATED COORDINATE ERROR.                         
REMARK   3   ESD FROM C-V LUZZATI PLOT    (A) : NULL                            
REMARK   3   ESD FROM C-V SIGMAA          (A) : NULL                            
REMARK   3                                                                      
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES.                                   
REMARK   3   BOND LENGTHS                 (A) : 0.007                           
REMARK   3   BOND ANGLES            (DEGREES) : 1.340                           
REMARK   3   DIHEDRAL ANGLES        (DEGREES) : NULL                            
REMARK   3   IMPROPER ANGLES        (DEGREES) : NULL                            
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL MODEL : NULL                                      
REMARK   3                                                                      
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.    RMS    SIGMA                
REMARK   3   MAIN-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   MAIN-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN BOND              (A**2) : NULL  ; NULL                 
REMARK   3   SIDE-CHAIN ANGLE             (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  NCS MODEL : NULL                                                    
REMARK   3                                                                      
REMARK   3  NCS RESTRAINTS.                         RMS   SIGMA/WEIGHT          
REMARK   3   GROUP  1  POSITIONAL            (A) : NULL  ; NULL                 
REMARK   3   GROUP  1  B-FACTOR           (A**2) : NULL  ; NULL                 
REMARK   3                                                                      
REMARK   3  PARAMETER FILE  1  : NULL                                           
REMARK   3  TOPOLOGY FILE  1   : NULL                                           
REMARK   3                                                                      
REMARK   3  OTHER REFINEMENT REMARKS: NULL                                      
REMARK   4                                                                      
REMARK   4 1LY2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11                         
REMARK 100                                                                      
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUN-02.                  
REMARK 100 THE DEPOSITION ID IS D_1000016398.                                   
REMARK 200                                                                      
REMARK 200 EXPERIMENTAL DETAILS                                                 
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION                  
REMARK 200  DATE OF DATA COLLECTION        : 01-FEB-01                          
REMARK 200  TEMPERATURE           (KELVIN) : 100                                
REMARK 200  PH                             : 7.5                                
REMARK 200  NUMBER OF CRYSTALS USED        : 2                                  
REMARK 200                                                                      
REMARK 200  SYNCHROTRON              (Y/N) : Y                                  
REMARK 200  RADIATION SOURCE               : NSLS                               
REMARK 200  BEAMLINE                       : X25                                
REMARK 200  X-RAY GENERATOR MODEL          : NULL                               
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M                                  
REMARK 200  WAVELENGTH OR RANGE        (A) : 1.05                               
REMARK 200  MONOCHROMATOR                  : WIGGLER                            
REMARK 200  OPTICS                         : WIGGLER                            
REMARK 200                                                                      
REMARK 200  DETECTOR TYPE                  : CCD                                
REMARK 200  DETECTOR MANUFACTURER          : CUSTOM-MADE                        
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : DENZO                              
REMARK 200  DATA SCALING SOFTWARE          : SCALEPACK                          
REMARK 200                                                                      
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 11265                              
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.800                              
REMARK 200  RESOLUTION RANGE LOW       (A) : 30.000                             
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL                               
REMARK 200                                                                      
REMARK 200 OVERALL.                                                             
REMARK 200  COMPLETENESS FOR RANGE     (%) : 88.4                               
REMARK 200  DATA REDUNDANCY                : NULL                               
REMARK 200  R MERGE                    (I) : NULL                               
REMARK 200  R SYM                      (I) : NULL                               
REMARK 200  <I/SIGMA(I)> FOR THE DATA SET  : NULL                               
REMARK 200                                                                      
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.                                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80                     
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.90                     
REMARK 200  COMPLETENESS FOR SHELL     (%) : 55.8                               
REMARK 200  DATA REDUNDANCY IN SHELL       : NULL                               
REMARK 200  R MERGE FOR SHELL          (I) : NULL                               
REMARK 200  R SYM FOR SHELL            (I) : 0.10000                            
REMARK 200  <I/SIGMA(I)> FOR SHELL         : NULL                               
REMARK 200                                                                      
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH                              
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT        
REMARK 200 SOFTWARE USED: AMORE                                                 
REMARK 200 STARTING MODEL: CRYSTAL STRUCTURE OF LIGANDED CD21 (COMPLEX WITH     
REMARK 200  C3D)                                                                
REMARK 200                                                                      
REMARK 200 REMARK: NULL                                                         
REMARK 280                                                                      
REMARK 280 CRYSTAL                                                              
REMARK 280 SOLVENT CONTENT, VS   (%): 50.41                                     
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.48                     
REMARK 280                                                                      
REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 4000, PH 7.5, VAPOR DIFFUSION,       
REMARK 280  HANGING DROP AT 298K, TEMPERATURE 298.0K                            
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY                                            
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1                              
REMARK 290                                                                      
REMARK 290      SYMOP   SYMMETRY                                                
REMARK 290     NNNMMM   OPERATOR                                                
REMARK 290       1555   X,Y,Z                                                   
REMARK 290                                                                      
REMARK 290     WHERE NNN -> OPERATOR NUMBER                                     
REMARK 290           MMM -> TRANSLATION VECTOR                                  
REMARK 290                                                                      
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS                            
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM             
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY                
REMARK 290 RELATED MOLECULES.                                                   
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000            
REMARK 290                                                                      
REMARK 290 REMARK: NULL                                                         
REMARK 300                                                                      
REMARK 300 BIOMOLECULE: 1                                                       
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM                
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN                  
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON               
REMARK 300 BURIED SURFACE AREA.                                                 
REMARK 350                                                                      
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN           
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE                
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS          
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND                          
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.                               
REMARK 350                                                                      
REMARK 350 BIOMOLECULE: 1                                                       
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC                         
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A                                     
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000            
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000            
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000            
DBREF  1LY2 A    0   129  UNP    P20023   CR2_HUMAN       20    149             
SEQADV 1LY2 GLU A    0  UNP  P20023    GLY    20 CLONING ARTIFACT               
SEQADV 1LY2 ALA A    1  UNP  P20023    ILE    21 CLONING ARTIFACT               
SEQADV 1LY2 ILE A  129  UNP  P20023    VAL   149 CLONING ARTIFACT               
SEQRES   1 A  130  GLU ALA SER CYS GLY SER PRO PRO PRO ILE LEU ASN GLY          
SEQRES   2 A  130  ARG ILE SER TYR TYR SER THR PRO ILE ALA VAL GLY THR          
SEQRES   3 A  130  VAL ILE ARG TYR SER CYS SER GLY THR PHE ARG LEU ILE          
SEQRES   4 A  130  GLY GLU LYS SER LEU LEU CYS ILE THR LYS ASP LYS VAL          
SEQRES   5 A  130  ASP GLY THR TRP ASP LYS PRO ALA PRO LYS CYS GLU TYR          
SEQRES   6 A  130  PHE ASN LYS TYR SER SER CYS PRO GLU PRO ILE VAL PRO          
SEQRES   7 A  130  GLY GLY TYR LYS ILE ARG GLY SER THR PRO TYR ARG HIS          
SEQRES   8 A  130  GLY ASP SER VAL THR PHE ALA CYS LYS THR ASN PHE SER          
SEQRES   9 A  130  MET ASN GLY ASN LYS SER VAL TRP CYS GLN ALA ASN ASN          
SEQRES  10 A  130  MET TRP GLY PRO THR ARG LEU PRO THR CYS VAL SER ILE          
MODRES 1LY2 ASN A  101  ASN  GLYCOSYLATION SITE                                 
MODRES 1LY2 ASN A  107  ASN  GLYCOSYLATION SITE                                 
HET    NAG  A1001      14                                                       
HET    NAG  A1002      14                                                       
HETNAM     NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE                         
FORMUL   2  NAG    2(C8 H15 N O6)                                               
FORMUL   4  HOH   *146(H2 O)                                                    
SHEET    1   A 2 SER A   2  CYS A   3  0                                        
SHEET    2   A 2 ILE A  21  ALA A  22 -1  O  ILE A  21   N  CYS A   3           
SHEET    1   B 4 GLY A  12  ILE A  14  0                                        
SHEET    2   B 4 VAL A  26  CYS A  31 -1  O  SER A  30   N  ARG A  13           
SHEET    3   B 4 SER A  42  ILE A  46 -1  O  LEU A  43   N  ILE A  27           
SHEET    4   B 4 THR A  54  TRP A  55 -1  O  THR A  54   N  ILE A  46           
SHEET    1   C 2 PHE A  35  ILE A  38  0                                        
SHEET    2   C 2 LYS A  61  TYR A  64 -1  O  LYS A  61   N  ILE A  38           
SHEET    1   D 2 SER A  70  CYS A  71  0                                        
SHEET    2   D 2 TYR A  88  ARG A  89 -1  O  TYR A  88   N  CYS A  71           
SHEET    1   E 4 GLY A  79  ARG A  83  0                                        
SHEET    2   E 4 SER A  93  CYS A  98 -1  O  ALA A  97   N  TYR A  80           
SHEET    3   E 4 SER A 109  CYS A 112 -1  O  VAL A 110   N  VAL A  94           
SHEET    4   E 4 TRP A 118  GLY A 119 -1  O  GLY A 119   N  TRP A 111           
SHEET    1   F 2 PHE A 102  ASN A 105  0                                        
SHEET    2   F 2 THR A 125  SER A 128 -1  O  VAL A 127   N  SER A 103           
SSBOND   1 CYS A    3    CYS A   45                          1555   1555  2.04  
SSBOND   2 CYS A   31    CYS A   62                          1555   1555  2.04  
SSBOND   3 CYS A   71    CYS A  112                          1555   1555  2.05  
SSBOND   4 CYS A   98    CYS A  126                          1555   1555  2.05  
LINK         ND2 ASN A 101                 C1  NAG A1001     1555   1555  1.46  
LINK         ND2 ASN A 107                 C1  NAG A1002     1555   1555  1.46  
CISPEP   1 THR A   19    PRO A   20          0        -0.16                     
CISPEP   2 THR A   86    PRO A   87          0        -0.22                     
CISPEP   3 GLY A  119    PRO A  120          0         0.15                     
CRYST1   31.600   33.270   42.110  91.51 111.44 117.81 P 1           1          
ORIGX1      1.000000  0.000000  0.000000        0.00000                         
ORIGX2      0.000000  1.000000  0.000000        0.00000                         
ORIGX3      0.000000  0.000000  1.000000        0.00000                         
SCALE1      0.031646  0.016692  0.016910        0.00000                         
SCALE2      0.000000  0.033982  0.008369        0.00000                         
SCALE3      0.000000  0.000000  0.026275        0.00000                         
ATOM      2  CA  GLU A   0     -21.209  11.651   9.356  1.00 28.28           C  
ATOM     11  CA  ALA A   1     -18.646  10.299  11.826  1.00 24.74           C  
ATOM     16  CA  SER A   2     -19.872   9.613  15.358  1.00 21.61           C  
ATOM     22  CA  CYS A   3     -18.543   8.432  18.729  1.00 19.87           C  
ATOM     28  CA  GLY A   4     -19.405   5.304  20.664  1.00 15.32           C  
ATOM     32  CA  SER A   5     -20.615   5.269  24.278  1.00 24.96           C  
ATOM     38  CA  PRO A   6     -18.506   7.492  26.604  1.00 17.21           C  
ATOM     45  CA  PRO A   7     -16.102   5.687  28.947  1.00 18.35           C  
ATOM     52  CA  PRO A   8     -18.078   4.816  32.117  1.00 18.10           C  
ATOM     59  CA  ILE A   9     -17.067   6.087  35.581  1.00 11.97           C  
ATOM     67  CA  LEU A  10     -17.200   4.183  38.888  1.00 14.49           C  
ATOM     75  CA  ASN A  11     -19.070   6.168  41.576  1.00 10.74           C  
ATOM     83  CA  GLY A  12     -19.486   9.105  39.201  1.00 10.32           C  
ATOM     87  CA  ARG A  13     -22.017  10.630  36.798  1.00 12.53           C  
ATOM     98  CA  ILE A  14     -21.966  11.772  33.162  1.00  8.12           C  
ATOM    106  CA  SER A  15     -23.939  14.764  31.830  1.00  7.35           C  
ATOM    112  CA  TYR A  16     -26.598  14.351  29.136  1.00  9.35           C  
ATOM    124  CA  TYR A  17     -25.651  13.223  25.625  1.00 16.27           C  
ATOM    136  CA  SER A  18     -27.811  12.230  22.648  1.00 26.16           C  
ATOM    142  CA  THR A  19     -27.234   9.306  20.279  1.00 28.49           C  
ATOM    149  CA  PRO A  20     -25.786   9.100  17.678  1.00 26.28           C  
ATOM    156  CA  ILE A  21     -22.962  11.121  19.231  1.00 12.29           C  
ATOM    164  CA  ALA A  22     -21.928  13.777  16.693  1.00 12.40           C  
ATOM    169  CA  VAL A  23     -18.405  15.094  16.282  1.00 14.63           C  
ATOM    176  CA  GLY A  24     -18.173  18.176  18.471  1.00 11.54           C  
ATOM    180  CA  THR A  25     -20.223  16.641  21.287  1.00 10.17           C  
ATOM    187  CA  VAL A  26     -18.947  17.402  24.800  1.00  5.39           C  
ATOM    194  CA  ILE A  27     -19.873  15.486  27.974  1.00  9.25           C  
ATOM    202  CA  ARG A  28     -19.013  16.333  31.606  1.00  6.30           C  
ATOM    213  CA  TYR A  29     -18.024  13.951  34.410  1.00  6.50           C  
ATOM    225  CA  SER A  30     -18.640  14.556  38.137  1.00 10.17           C  
ATOM    231  CA  CYS A  31     -18.360  12.672  41.448  1.00 17.44           C  
ATOM    237  CA  SER A  32     -20.458  12.431  44.589  1.00 31.60           C  
ATOM    243  CA  GLY A  33     -19.423  14.475  47.641  1.00 19.86           C  
ATOM    247  CA  THR A  34     -17.321  11.783  49.339  1.00 26.52           C  
ATOM    254  CA  PHE A  35     -15.200  11.275  46.191  1.00 13.93           C  
ATOM    265  CA  ARG A  36     -12.802  13.541  44.321  1.00 11.98           C  
ATOM    276  CA  LEU A  37     -12.679  13.774  40.528  1.00  9.12           C  
ATOM    284  CA  ILE A  38      -9.174  13.103  39.205  1.00  9.14           C  
ATOM    292  CA  GLY A  39      -8.410  14.236  35.662  1.00  6.08           C  
ATOM    296  CA  GLU A  40     -10.034  16.576  33.110  1.00 10.39           C  
ATOM    305  CA  LYS A  41     -13.825  16.496  33.544  1.00 10.69           C  
ATOM    314  CA  SER A  42     -14.829  17.228  29.937  1.00 13.09           C  
ATOM    320  CA  LEU A  43     -14.574  14.864  26.962  1.00  8.90           C  
ATOM    328  CA  LEU A  44     -14.948  15.929  23.327  1.00  9.33           C  
ATOM    336  CA  CYS A  45     -15.942  13.736  20.367  1.00 15.09           C  
ATOM    342  CA  ILE A  46     -13.396  14.299  17.574  1.00 21.55           C  
ATOM    350  CA  THR A  47     -12.360  12.635  14.321  1.00 23.12           C  
ATOM    357  CA  LYS A  48      -8.867  12.255  12.871  1.00 36.82           C  
ATOM    366  CA  ASP A  49      -9.947  10.836   9.493  1.00 33.10           C  
ATOM    374  CA  LYS A  50     -13.559  12.102   9.244  1.00 31.91           C  
ATOM    383  CA  VAL A  51     -14.755   8.470   9.116  1.00 28.80           C  
ATOM    390  CA  ASP A  52     -14.552   7.230  12.734  1.00 28.36           C  
ATOM    398  CA  GLY A  53     -15.341   9.301  15.815  1.00 17.89           C  
ATOM    402  CA  THR A  54     -13.288   9.009  19.008  1.00 19.47           C  
ATOM    409  CA  TRP A  55     -13.240  10.715  22.411  1.00  7.78           C  
ATOM    423  CA  ASP A  56     -10.320  13.150  22.735  1.00 10.39           C  
ATOM    431  CA  LYS A  57      -9.032  11.763  26.036  1.00 13.85           C  
ATOM    440  CA  PRO A  58      -9.512   9.004  28.636  1.00  9.31           C  
ATOM    447  CA  ALA A  59     -12.345   9.513  31.094  1.00  9.05           C  
ATOM    452  CA  PRO A  60     -11.421  10.871  34.546  1.00  7.45           C  
ATOM    459  CA  LYS A  61     -12.020   8.785  37.700  1.00 14.20           C  
ATOM    468  CA  CYS A  62     -13.560   9.255  41.153  1.00  7.40           C  
ATOM    474  CA  GLU A  63     -11.253   8.472  44.079  1.00 12.42           C  
ATOM    483  CA  TYR A  64     -12.658   7.990  47.592  1.00 10.35           C  
ATOM    495  CA  PHE A  65     -11.566  11.069  49.561  1.00  8.34           C  
ATOM    506  CA  ASN A  66      -8.390  10.544  51.591  1.00 11.78           C  
ATOM    514  CA  LYS A  67      -8.143  13.549  53.918  1.00 11.75           C  
ATOM    523  CA  TYR A  68      -4.495  12.898  54.816  1.00  9.63           C  
ATOM    535  CA  SER A  69      -3.160  12.999  51.260  1.00 12.20           C  
ATOM    541  CA  SER A  70      -1.094  15.942  50.012  1.00 13.54           C  
ATOM    547  CA  CYS A  71       1.187  16.569  47.041  1.00 13.03           C  
ATOM    553  CA  PRO A  72       4.522  18.424  46.798  1.00 17.91           C  
ATOM    560  CA  GLU A  73       4.865  21.581  44.651  1.00 18.69           C  
ATOM    569  CA  PRO A  74       4.755  20.401  41.014  1.00 12.80           C  
ATOM    576  CA  ILE A  75       7.475  21.970  38.858  1.00 13.82           C  
ATOM    584  CA  VAL A  76       7.594  22.281  35.062  1.00  7.46           C  
ATOM    591  CA  PRO A  77      10.887  23.717  33.684  1.00 12.67           C  
ATOM    598  CA  GLY A  78      10.157  26.427  31.106  1.00  8.60           C  
ATOM    602  CA  GLY A  79       6.629  26.826  32.453  1.00  6.80           C  
ATOM    606  CA  TYR A  80       4.813  28.379  35.380  1.00 10.16           C  
ATOM    618  CA  LYS A  81       1.774  27.743  37.560  1.00 11.49           C  
ATOM    627  CA  ILE A  82      -1.240  29.892  36.619  1.00 16.71           C  
ATOM    635  CA  ARG A  83      -3.731  28.353  39.042  1.00 13.50           C  
ATOM    646  CA  GLY A  84      -3.434  26.357  42.256  1.00 20.56           C  
ATOM    650  CA  SER A  85      -2.495  27.140  45.842  1.00 29.49           C  
ATOM    656  CA  THR A  86      -0.623  25.249  48.547  1.00 28.71           C  
ATOM    663  CA  PRO A  87      -1.327  23.036  50.439  1.00 20.89           C  
ATOM    670  CA  TYR A  88      -2.341  20.597  47.699  1.00 12.22           C  
ATOM    682  CA  ARG A  89      -4.858  18.146  49.149  1.00 17.19           C  
ATOM    693  CA  HIS A  90      -6.622  15.206  47.491  1.00  8.20           C  
ATOM    703  CA  GLY A  91      -8.621  16.378  44.487  1.00  8.18           C  
ATOM    707  CA  ASP A  92      -6.850  19.753  44.211  1.00 10.15           C  
ATOM    715  CA  SER A  93      -5.445  20.720  40.831  1.00 12.05           C  
ATOM    721  CA  VAL A  94      -2.721  22.957  39.415  1.00 10.36           C  
ATOM    728  CA  THR A  95      -2.663  24.446  35.894  1.00  8.13           C  
ATOM    735  CA  PHE A  96       0.494  25.501  34.019  1.00  7.25           C  
ATOM    746  CA  ALA A  97       1.308  27.831  31.116  1.00  8.94           C  
ATOM    751  CA  CYS A  98       4.587  27.878  29.235  1.00 14.56           C  
ATOM    757  CA  LYS A  99       6.882  30.897  29.458  1.00  6.23           C  
ATOM    766  CA  THR A 100       7.359  33.229  26.506  1.00 11.22           C  
ATOM    773  CA  ASN A 101       9.014  31.341  23.615  1.00 19.92           C  
ATOM    781  CA  PHE A 102       8.177  27.919  25.064  1.00  9.35           C  
ATOM    792  CA  SER A 103       5.520  25.532  23.744  1.00 10.30           C  
ATOM    798  CA  MET A 104       3.664  22.899  25.765  1.00  6.80           C  
ATOM    806  CA  ASN A 105       3.330  19.159  25.186  1.00 10.65           C  
ATOM    814  CA  GLY A 106       0.730  17.417  27.317  1.00  8.00           C  
ATOM    818  CA  ASN A 107      -2.126  18.308  29.610  1.00 16.38           C  
ATOM    826  CA  LYS A 108      -1.879  21.701  31.240  1.00 11.19           C  
ATOM    835  CA  SER A 109      -3.523  20.518  34.478  1.00 12.11           C  
ATOM    841  CA  VAL A 110      -2.697  17.771  36.979  1.00  8.38           C  
ATOM    848  CA  TRP A 111      -4.498  16.585  40.127  1.00 10.21           C  
ATOM    862  CA  CYS A 112      -3.310  15.577  43.572  1.00 10.91           C  
ATOM    868  CA  GLN A 113      -4.138  11.856  43.860  1.00 12.11           C  
ATOM    877  CA  ALA A 114      -4.804   9.736  46.967  1.00 12.03           C  
ATOM    882  CA  ASN A 115      -1.380   8.110  46.496  1.00 13.22           C  
ATOM    890  CA  ASN A 116       0.161  11.552  47.085  1.00 11.27           C  
ATOM    898  CA  MET A 117       1.350  11.930  43.502  1.00 16.10           C  
ATOM    906  CA  TRP A 118       0.310  14.225  40.669  1.00 11.21           C  
ATOM    920  CA  GLY A 119      -1.740  12.605  37.911  1.00  6.97           C  
ATOM    924  CA  PRO A 120      -3.391  10.952  36.128  1.00 10.72           C  
ATOM    931  CA  THR A 121      -0.918  12.012  33.417  1.00  8.94           C  
ATOM    938  CA  ARG A 122       2.730  13.031  33.494  1.00 10.21           C  
ATOM    949  CA  LEU A 123       3.327  16.746  34.166  1.00  5.60           C  
ATOM    957  CA  PRO A 124       3.397  18.735  30.882  1.00  9.28           C  
ATOM    964  CA  THR A 125       6.669  19.596  29.112  1.00 13.49           C  
ATOM    971  CA  CYS A 126       7.463  23.163  28.024  1.00  7.43           C  
ATOM    977  CA  VAL A 127       9.964  23.226  25.139  1.00 13.23           C  
ATOM    984  CA  SER A 128      11.896  26.276  23.892  1.00 13.82           C  
ATOM    990  CA  ILE A 129      10.917  27.054  20.270  1.00 28.10           C  
TER     997      ILE A 129                                                      
CONECT   26  340                                                                
CONECT  235  472                                                                
CONECT  340   26                                                                
CONECT  472  235                                                                
CONECT  551  866                                                                
CONECT  755  975                                                                
CONECT  779  998                                                                
CONECT  824 1012                                                                
CONECT  866  551                                                                
CONECT  975  755                                                                
CONECT  998  779  999 1009                                                      
CONECT  999  998 1000 1006                                                      
CONECT 1000  999 1001 1007                                                      
CONECT 1001 1000 1002 1008                                                      
CONECT 1002 1001 1003 1009                                                      
CONECT 1003 1002 1010                                                           
CONECT 1004 1005 1006 1011                                                      
CONECT 1005 1004                                                                
CONECT 1006  999 1004                                                           
CONECT 1007 1000                                                                
CONECT 1008 1001                                                                
CONECT 1009  998 1002                                                           
CONECT 1010 1003                                                                
CONECT 1011 1004                                                                
CONECT 1012  824 1013 1023                                                      
CONECT 1013 1012 1014 1020                                                      
CONECT 1014 1013 1015 1021                                                      
CONECT 1015 1014 1016 1022                                                      
CONECT 1016 1015 1017 1023                                                      
CONECT 1017 1016 1024                                                           
CONECT 1018 1019 1020 1025                                                      
CONECT 1019 1018                                                                
CONECT 1020 1013 1018                                                           
CONECT 1021 1014                                                                
CONECT 1022 1015                                                                
CONECT 1023 1012 1016                                                           
CONECT 1024 1017                                                                
CONECT 1025 1018                                                                
MASTER      188    0    2    0   16    0    0    6 1170    1   38   10          
END                                                                             
